Could a tiny port replace daily insulin shots for pregnant women?

NCT ID NCT07165327

First seen Jun 26, 2026 ยท Last updated Jun 26, 2026

Summary

This study compares using an injection port versus standard needles for insulin delivery in pregnant women with diabetes. The port stays on the skin for three days, allowing insulin to be given without repeated needle sticks. Researchers want to see if this approach helps women stick to their insulin schedule and feel more satisfied with their care.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Injection port device (i-port) for insulin administration
What this could lead to
If it works, this could offer a less painful and more convenient way for pregnant women with diabetes to take their insulin, potentially improving blood sugar control.
What could go wrong
This is a small, early-stage study with only 44 participants, so results may not apply to everyone. The port may cause skin irritation or not improve adherence as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES IN PREGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Texas at Austin, Dell Medical School

    Austin, Texas, 78705, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.